Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Natural History of Untreated Atrophic Lesions in AMD and Stargardt Disease: A Meta-analysis
Lucian V. Del Priore, MD, PhD
On Demand Cases, Courses, and Papers
2019

Category: AMD-Neovascular

See more